Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.
about
Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretionMechanism of action of 5-arninosalicylic acid.Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea.5-amino-salicylate in the management of inflammatory bowel disease.Steady-state pharmacokinetics of a new 4-gram 5-aminosalicylic acid retention enema in patients with ulcerative colitis in remission.
P2860
Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@ast
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@en
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@nl
type
label
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@ast
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@en
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@nl
prefLabel
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@ast
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@en
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@nl
P2093
P2860
P356
P1433
P1476
Longterm olsalazine treatment: ...... e colitis and Crohn's colitis.
@en
P2093
J Rask-Madsen
K Lauritsen
L Staerk Laursen
P2860
P304
P356
10.1136/GUT.29.7.974
P407
P577
1988-07-01T00:00:00Z